Credit Suisse’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-21,390
| Closed | -$321K | – | 3968 |
|
2016
Q2 | $321K | Sell |
21,390
-37,613
| -64% | -$564K | ﹤0.01% | 3366 |
|
2016
Q1 | $717K | Buy |
59,003
+38,990
| +195% | +$474K | ﹤0.01% | 2694 |
|
2015
Q4 | $319K | Buy |
20,013
+3,422
| +21% | +$54.5K | ﹤0.01% | 3435 |
|
2015
Q3 | $255K | Sell |
16,591
-32,031
| -66% | -$492K | ﹤0.01% | 3593 |
|
2015
Q2 | $1.18M | Buy |
48,622
+9,816
| +25% | +$238K | ﹤0.01% | 2776 |
|
2015
Q1 | $902K | Sell |
38,806
-24,277
| -38% | -$564K | ﹤0.01% | 2810 |
|
2014
Q4 | $1.58M | Buy |
63,083
+32,257
| +105% | +$810K | ﹤0.01% | 2427 |
|
2014
Q3 | $958K | Sell |
30,826
-2,966
| -9% | -$92.2K | ﹤0.01% | 2719 |
|
2014
Q2 | $874K | Sell |
33,792
-435,230
| -93% | -$11.3M | ﹤0.01% | 3007 |
|
2014
Q1 | $11M | Sell |
469,022
-585,213
| -56% | -$13.7M | 0.01% | 1028 |
|
2013
Q4 | $26.8M | Sell |
1,054,235
-613,296
| -37% | -$15.6M | 0.02% | 595 |
|
2013
Q3 | $34M | Sell |
1,667,531
-345,759
| -17% | -$7.05M | 0.03% | 415 |
|
2013
Q2 | $42.2M | Buy |
+2,013,290
| New | +$42.2M | 0.04% | 376 |
|